Melodi Health raised $10.75M in a Series A funding led by undisclosed investors to further its pivotal breast reconstruction trial.
Melodi Health raised $10.75M in a Series A funding led by undisclosed investors to further its pivotal breast reconstruction trial.
09/02/24, 2:20 PM
Location
minneapolisMoney raised
$10.8 million
Industry
health care
Round Type
series a
Melodi Health has successfully secured $10.75 million in Series A funding. This investment will support the enrollment of the first patient in its pivotal breast reconstruction trial.
Company Info
Location
1414 marshall st. ne
minneapolis, minnesota, united states
Additional Info
Melodi Health offers novel technologies that improve patient outcomes for women undergoing breast surgery.
Melodi Health manufactures the Melodi Matrix, designed to support the soft tissue space around a prosthetic device while delivering antibiotics to the surrounding tissue. The Melodi Matrix is currently an investigational device being studied in a prospective, multi-center, randomized, controlled clinical trial in breast reconstruction.